CERo Therapeutics Holdings, Inc.
CERO
$0.02
$0.0159.05%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.92M | -14.71M | -14.08M | -11.11M | -8.30M |
| Total Depreciation and Amortization | 1.09M | 1.09M | 1.12M | 1.14M | 1.16M |
| Total Amortization of Deferred Charges | 605.40K | 500.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.96M | -2.04M | -2.14M | -4.99M | -7.61M |
| Change in Net Operating Assets | 189.20K | 1.33M | 1.73M | 2.67M | 1.84M |
| Cash from Operations | -16.08M | -13.81M | -13.37M | -12.28M | -12.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 500.00K | 500.00K | -- | -- | -- |
| Cash from Investing | 500.00K | 500.00K | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 408.10K |
| Total Debt Repaid | -- | -102.30K | -253.20K | -402.50K | -422.20K |
| Issuance of Common Stock | 6.71M | 5.92M | 7.83M | 5.10M | 9.34M |
| Repurchase of Common Stock | -962.00K | -962.00K | -- | -4.53M | -4.53M |
| Issuance of Preferred Stock | 5.76M | 4.07M | 2.69M | 9.95M | 9.45M |
| Repurchase of Preferred Stock | -395.00K | -395.00K | -395.00K | -395.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.81M | 3.42M | 3.16M | 3.17M | -514.40K |
| Cash from Financing | 13.92M | 11.96M | 13.02M | 12.89M | 13.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.66M | -1.36M | -344.30K | 610.50K | 811.70K |